Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today

©(c) provided by Benzinga

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase at 37,903.29, while the S&P 500 finished lower by 0.3% at 5,018.39. Similarly, the Nasdaq ended the day down 0.33% at 15,605.48.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Carvana Co. (NYSE:CVNA)

Carvana’s stock jumped 5.03% to close at $87.09 after reporting strong first-quarter earnings. The company’s revenue of $3.061 billion beat the consensus estimate, and it sold 91,878 vehicles, a 16% increase year-over-year.

Enovix Corporation (NASDAQ:ENVX)

Enovix’s stock soared 3.99% to close at $6.51. Despite missing the analyst consensus estimate with quarterly losses of 31 cents per share, the company reported blockbuster first-quarter sales of $5.272 million, a significant increase from the same period last year.

See Also: Goldman Sachs Tempers Investor Excitement On Tesla Self-Driving Tech In China: ‘Not Yet An Eyes-Off, Unsupervised Product’

Pfizer Inc. (NYSE:PFE)

Pfizer’s stock rose 6.09% to close at $27.18. The company reported first-quarter adjusted EPS of $0.82, beating the consensus of $0.54, despite a 33% year-over-year decrease. Sales were down 20% to $14.9 billion, still beating the consensus of $14.2 billion.

NIO Inc. (NYSE:NIO)

NIO’s shares gained 11.65% to close at $5.27. The company reported a 134.6% year-over-year increase in April vehicle deliveries, reaching a total of 15,620 vehicles.

Tesla Inc. (NASDAQ:TSLA)

Tesla’s stock fell 1.79% to close at $180, despite news of a potential full self-driving software rollout in China.

Photo by Jirapong Manustrong on Shutterstock

Prepare for the day’s trading [with top premarket movers and news]( by Benzinga.

Read Next: Supreme Court: Drivers Hauling Baked Goods Are in Transportation, Not Baking


Engineered by
Benzinga Neuro, Edited by

Shivdeep Dhaliwal


The GPT-4-based Benzinga Neuro content generation system exploits the
extensive Benzinga Ecosystem, including native data, APIs, and more to
create comprehensive and timely stories for you.
Learn more.


© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.